19 Panel Dip Card
The 19 panel dip card is a fast, reliable, and easy-to-use urine screening device designed to
detect ten commonly abused drugs in a single test format. This multi-drug detection dip card
is widely used in workplaces, rehabilitation programs, probation monitoring, healthcare screening,
law enforcement, and personal testing where accurate and efficient drug screening is required.
Showing the single result
Dip card 19 Panel Detects GAB, KRA, ETG, FEN & ADLTX, Short Date Sale, Experation Date, 12/13/26, As low as $1.05
AMP, BAR, BUP, BZO, COC, EtG, FEN, KRA, MDMA, MET, MTD, OPI/MOR, OXY, PCP, TCA, THC, GABAForensic UseAs low As$1.05 $1.05 - $1.29
Bulk Pricing that Cuts the Budget in Half
Priority Shipping For Bulk Orders.
Dedicated Wholesale Representative.
Quality That Is Reliable For the Nation.
Key Features of 19 Panel Dip Card
The Serenity 19 Panel Dip Card is the most comprehensive dip card in the 12 Panel Now dip card range. Five specialty panels — Gabapentin, Kratom, EtG, Fentanyl, and TCA are added to the complete 12 panel professional baseline alongside built-in ADLTX specimen validity. Forensic Use Only. Currently on short date sale at $1.05 per card. Results in 5 minutes. Same-day shipping.
- Rapid results – preliminary screening complete in 5 to 10 minutes for 6 types of drugs and variants
- Fully observed collection – tamper-resistant process with no restroom needed
- On-site ready – no lab, no special equipment, no collection facility required
- Detects recent use – identifies drug use within the past 24 to 48 hours
- Minimal training required – straightforward administration for any staff member
- Individually sealed sterile devices – hygienic single-use packaging for every test
19 Panel Multi Dip Card Test specifications
| Code | Full Substance Name | Cutoff | What It Catches |
|---|---|---|---|
| AMP | Amphetamines | 1000 ng/mL | Adderall, Vyvanse, prescription and illicit amphetamines |
| BAR | Barbiturates | 300 ng/mL | Phenobarbital, butalbital, secobarbital |
| BUP | Buprenorphine | 10 ng/mL | Suboxone, Subutex — detects MAT compliance at therapeutic concentrations a standard OPI strip misses |
| BZO | Benzodiazepines | 300 ng/mL | Xanax, Valium, Klonopin, Ativan |
| COC | Cocaine | 300 ng/mL | Cocaine, crack cocaine |
| EtG | Ethyl Glucuronide | 300 ng/mL | Alcohol metabolite — detects consumption up to 80 hours post-use. Not present on any standard multi-panel drug test |
| FEN | Fentanyl | 20 ng/mL | Illicit fentanyl and primary fentanyl analogs — does not cross-react with standard OPI panel. Mandated in SAMHSA federal panels July 2025 |
| GABA | Gabapentin | 1000 ng/mL | Neurontin, pregabalin — the primary specialty panel on this card. Widely misused in opioid-adjacent populations. Not detected on any standard drug panel at any count |
| KRA | Kratom | 500 ng/mL | Mitragyna speciosa — opioid receptor activity. Passes all OPI, BUP, and MTD panels undetected. Not on any standard panel |
| MDMA | Methylenedioxymethamphetamine | 500 ng/mL | Ecstasy, Molly — independent dedicated panel |
| MET | Methamphetamine | 1000 ng/mL | Crystal meth, street methamphetamine |
| MTD | Methadone | 300 ng/mL | Methadone maintenance — does not appear on standard OPI strip |
| OPI/MOR | Opiates / Morphine | 300 ng/mL | Heroin, codeine, morphine |
| OXY | Oxycodone | 100 ng/mL | OxyContin, Percocet — does not appear on standard OPI strip |
| PCP | Phencyclidine | 25 ng/mL | PCP, angel dust |
| TCA | Tricyclic Antidepressants | 1000 ng/mL | Amitriptyline, nortriptyline, doxepin — monitored in pain management and court supervision programs |
| THC | Marijuana / Cannabis | 50 ng/mL | Cannabis, edibles, concentrates |
| ADLTX — Built-In Specimen Validity (pH, Specific Gravity, Creatinine — counted in the 19 panel positions) | |||
| pH | Urine pH | 3.0 to 11.0 | Flags chemical adulteration outside normal urinary pH range |
| SG | Specific Gravity | 1.001 to 1.030 | Detects diluted or substituted specimens |
| CRE | Creatinine | 2 to 300 mg/dL | Confirms biological origin and concentration of the specimen |
| Product | All Panel Positions | Classification | From |
|---|---|---|---|
| 19 Panel Dip Card — GAB, KRA, EtG, FEN, TCA and ADLTX SHORT DATE SALE — Expiry 12/13/2026 SKU: SM-DOA-6195FUO |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | GABA/1000ng | KRA/500ng | TCA/1000ng MDMA | MET | MTD | OPI/MOR | OXY | PCP | THC + pH | Specific Gravity | Creatinine (ADLTX) |
Forensic Use Only | $1.05 Short Date |
Confirm stock availability and verify usage timeline fits before bulk ordering. Forensic Use Only — all presumptive positive results require GC-MS or LC-MS/MS laboratory confirmation. Results in 5 minutes. Requires separate urine collection container. For bulk pricing call 561-897-9238 or email [email protected].
Comparing dip card ranges: 18 panel dip card at $1.03 (short date). 17 panel dip card from $0.99. 15 panel dip card at $0.97. Full dip card range.
Easy Steps To Use The 19 Panel Dip Card
Step 1 — Collect
Remove the drug test cup from its sealed pouch and use it as soon as possible. Have the subject provide a urine sample directly into the cup, filling to the indicated line.
Step 2 — Dip & Wait
At 2–4 minutes, verify the temperature of the specimen using the built-in temperature strip. A green indicator confirms the sample is valid and within the acceptable range of 90–100°F.
Step 3 — Read
Peel back the label when ready to interpret results. Read results within 5 minutes of collection. Do not read results after 8 minutes, as the extended window may affect accuracy.
Positive
Two colored bands appear — one in the control region (C) and one in the test region (T). This indicates no drug was detected above the cutoff level.
Negative
Two colored bands appear, one in the control region (C) and another in the test region (T) for the drug in question.
Invalid
The control band fails to appear entirely. Discard the test and retest with a fresh cup within 3 minutes. If the problem persists, contact your distributor.
What is Included in a 19 Panel Dip Card?
The 19 panel dip card (SM-DOA-6195FUO) from 12 Panel Now is the highest-panel configuration in the 12 Panel Now dip card range. It covers the complete 12 panel professional baseline — AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC — plus five specialty additions that no standard multi-panel configuration at any count detects: Gabapentin (GABA), Kratom (KRA), Ethyl Glucuronide (EtG), Fentanyl (FEN), and Tricyclic Antidepressants (TCA). Built-in ADLTX specimen validity (pH, Specific Gravity, Creatinine) runs simultaneously alongside all drug panels in the same 5-minute dip event. Currently on short date sale at $1.05
The five specialty panels and what they detect that the 12 panel baseline cannot:
GABA / Gabapentin at 1000 ng/mL — The Single Most Significant Undetected Substance in Opioid-Adjacent Populations
Gabapentin (Neurontin, generics widely available) is a prescription anticonvulsant prescribed for nerve pain, epilepsy, and restless leg syndrome. It is widely misused in opioid treatment populations because it potentiates opioid effects, produces euphoria and sedation at high doses, and is accessible by prescription or through diverted supply. It produces a completely negative result on every panel of every standard drug test at any panel count because no standard immunoassay drug test panel includes a Gabapentin antibody. Per NIDA prescription drug misuse data, gabapentin misuse is significantly documented in opioid use disorder populations served by MAT programs, correctional facilities, and pain management clinics. The dedicated GABA panel at 1000 ng/mL on the 19 panel card is the only available point-of-care multi-panel screening method for gabapentin. Also available as a specialty addition on the 17 panel FUO dip card ($0.99) and the 15 panel dip card ($0.97).
KRA / Kratom at 500 ng/mL — The Legal Opioid Receptor Substance That Passes Every OPI, BUP, and MTD Panel
Kratom (Mitragyna speciosa) binds to mu-opioid receptors but its alkaloids are structurally distinct from all opiate and opioid compounds detected by standard OPI, BUP, and MTD antibodies. It is legally sold at retail in most US states and documented in treatment, correctional, and court supervision populations as a self-managed opioid substitute. The dedicated KRA panel at 500 ng/mL provides the only available rapid point-of-care detection. Also available in the 16 panel dip card, 17 panel, and 18 panel dip card ranges.
EtG / Ethyl Glucuronide at 300 ng/mL — 80-Hour Alcohol Monitoring Across the Inter-Test Interval
EtG is the primary urinary metabolite of ethanol, detectable for 24 to 80 hours post-consumption. For sober living programs, drug courts, and MAT clinics conducting weekly urine collections, EtG at 300 ng/mL covers approximately 70% of the 168-hour weekly inter-test interval — the alcohol monitoring window where no breathalyzer or direct alcohol test can reach. Per SAMHSA MAT guidelines, concurrent alcohol monitoring is a required compliance component.
FEN / Fentanyl at 20 ng/mL — Federal Mandate Compliance in Every Card
Fentanyl does not cross-react with any standard OPI antibody at illicit-use concentrations per NIDA fentanyl research. The dedicated FEN panel at 20 ng/mL detects illicit fentanyl and primary analogs for 12 to 48 hours post-use. Added to SAMHSA federal workplace testing panels effective July 2025. Confirmed in drug supply in all 50 US states per CDC overdose data.
TCA / Tricyclic Antidepressants at 1000 ng/mL — Prescription Antidepressant Monitoring for Pain and Court Programs
The TCA panel detects tricyclic antidepressants — amitriptyline, nortriptyline, and doxepin — at 1000 ng/mL. TCA monitoring is specified in many pain management protocols where TCA co-prescription with opioids creates a monitored sedation risk, and in some court supervision orders specifying TCA compliance monitoring. Tricyclics are not detected on any standard drug panel at any count without a dedicated TCA antibody.
ADLTX — pH, Specific Gravity, Creatinine — Simultaneous Specimen Validity Built Into the Card
The ADLTX markers run simultaneously alongside all drug panels in the same 5-minute dip event. For drug courts, correctional facilities, and any forensic program where results may enter legal proceedings, simultaneous ADLTX documentation provides specimen integrity evidence from the same collection event without any additional strip, additional cost, or additional workflow step. The same ADLTX format is also built into the 18 panel dip card.
19 Panel in Context: The Top of the Dip Card Range
The 19 panel card sits at the top of the 12 Panel Now dip card range. Programs comparing the 18 panel card (KET, TRA, EtG, FEN, KRA, ADLTX) with the 19 panel card should note the key distinction: the 19 panel card adds GABA and TCA to the standard professional baseline alongside EtG, FEN, KRA, and ADLTX. Programs where Gabapentin and TCA monitoring are priorities should select the 19 panel. Programs where Ketamine and Tramadol detection are priorities should select the 18 panel dip card currently at $1.03
Features and Benefits
19 Panel Drug Test Dip Card from 12 Panel Now: The Most Comprehensive Dip Card Configuration Available — GABA, KRA, EtG, FEN, TCA and ADLTX Alongside the Complete Professional Baseline at $1.05 Per Card Short Date: The 19 panel dip card closes five specific detection gaps that no standard drug test at any panel count addresses — Gabapentin, Kratom, alcohol (via EtG), Fentanyl, and Tricyclic Antidepressants — with built-in ADLTX specimen validity, in one Forensic Use Only card at $1.05 per card in bulk on short date sale.
- GABA at 1000ng/mL: The Only Multi-Panel Dip Card That Catches Neurontin — The Most Documented Undetected Substance in MAT Populations: Gabapentin passes every panel of every standard drug test. The dedicated GABA panel at 1000 ng/mL is the only available point-of-care multi-panel detection method for gabapentin. For MAT programs, correctional facilities, and pain management clinics where Gabapentin monitoring is a documented clinical priority, the 19 panel card provides this detection capability as a standard panel alongside a comprehensive professional baseline.
- KRA at 500ng/mL: Kratom Detection — The Legal Opioid Substance That Passes Every Standard Screen: Kratom passes every OPI, BUP, and MTD panel because its alkaloids are structurally distinct from opiate compounds. Legally sold in most US states, it is documented as a self-managed opioid substitute in treatment and correctional populations. The KRA panel at 500 ng/mL is the only available rapid point-of-care detection for Kratom in a multi-panel format.
- EtG at 300ng/mL: 80-Hour Alcohol Monitoring Across the Full Weekly Collection Interval: EtG at 300 ng/mL covers the alcohol abstinence monitoring window between weekly collections for sober living programs, drug courts, and MAT clinics. No breathalyzer or direct alcohol test covers this interval. Per SAMHSA MAT guidelines, concurrent alcohol monitoring is a required compliance component.
- FEN at 20ng/mL: SAMHSA Federal Mandate Compliance on Every Card in This Range: Fentanyl was added to SAMHSA Mandatory Guidelines for federal workplace testing effective July 2025. The FEN panel at 20 ng/mL is a standard panel on the 19 panel card, covering illicit fentanyl and primary analogs confirmed in drug supply per CDC overdose data in all 50 US states.
- TCA at 1000ng/mL: Tricyclic Antidepressant Monitoring for Pain Management and Court Programs: The TCA panel at 1000 ng/mL covers amitriptyline, nortriptyline, and doxepin — monitoring required in many pain management protocols and some court supervision orders. TCA is not detected on any standard drug panel without a dedicated TCA antibody.
- ADLTX Built In: pH, Specific Gravity and Creatinine Run Alongside Every Drug Panel — No Additional Strip Required: ADLTX specimen validity runs in the same 5-minute dip event as all drug panels. For drug courts and correctional programs where results may enter legal proceedings, ADLTX provides simultaneous specimen integrity documentation at no additional cost, no additional strip, and no additional collection step.
- $1.05 Short Date Through 12/13/26 — Same-Day Shipping, 10% Price Beat, Wholesale Pricing at All Volumes: Bulk wholesale pricing at every order level. 10% price beat on any competing quote — send current supplier pricing to [email protected]. Same-day shipping on orders before 3:00 PM EST. Full OEM and private label for distributors and large programs. Confirm stock availability before placing large orders at 561-897-9238.
Contact for Bulk 19 Panel Dip Card Orders, Wholesale Pricing and Private Label: 561-897-9238 | [email protected]
Check other product variations
for Multi Dip Cards
From everyday staples to specialty products:
- Multi Strips
- 5 Panel Dip Cards
- 10 Panel Dip Cards
- 12 Panel Dip Cards
- 14 Panel Dip Cards
- 19 Panel Dip Cards
10 Panel Dip
13 Dip Panel
12 Panel Dip
Dip Cards
Buy in Bulk from 12 Panel Now and Get 10% off.
12 Panel Now offers the 19 Panel Dip Card (SM-DOA-6195FUO) at bulk wholesale pricing starting at $1.05 per card on short date. Tiered volume pricing is available at every order level. All orders placed before 3:00 PM EST ship the same day. Free shipping on qualifying bulk purchases.
The $1.05 short date price represents the most cost-effective pricing available for this configuration. At $1.05 per card, the 19 panel card delivers Gabapentin, Kratom, EtG, Fentanyl, and TCA detection alongside the complete professional baseline and built-in ADLTX validity five specialty panels that would cost significantly more if purchased as separate single-panel add-on strips per collection event. Programs running a standard 12 panel card and supplementing with separate specialty strips for these five substances spend approximately $2.50 to $3.00 per collection event in total. The 19 panel card consolidates all five specialty panels into one card at $1.05.
Programs considering the 18 panel dip card at $1.03 short date (Kratom, Ketamine, Tramadol, EtG, FEN, ADLTX) versus the 19 panel card at $1.05 short date should make the selection based on which specialty panel profile matches the documented substance monitoring needs of their specific population Ketamine and Tramadol coverage (18 panel) vs Gabapentin and TCA coverage (19 panel). For programs needing all of these specialty panels across their population, running both cards from the same specimen or contacting 12 Panel Now for a custom OEM configuration is the recommended approach.
12 Panel Now guarantees a price beat on any current supplier's documented pricing for the same product. Send your current supplier's quote to [email protected]. Call 561-897-9238 to confirm current stock availability at the $1.05 short date price and to verify stock levels before placing large bulk orders ahead of the 12/13/2026 expiry date.
OEM and Private Label — 19 Panel Dip Card
12 Panel Now manufactures the Serenity 19 Panel Dip Card and offers full OEM and private label programs for distributors, treatment networks, addiction treatment systems, pain management groups, court supply organizations, and drug testing companies that need a branded high-panel specialty dip card at manufacturer-direct pricing.
Private label options include:
- Custom foil pouch branding with your organization's logo, product name, and color scheme
- Custom card face printing with branded panel labeling, result guide, and ADLTX validity markers clearly marked
- Custom outer box and retail case packaging for distributor resale and institutional supply programs
- White-label configurations at volume pricing for regional and national distribution networks
- OEM manufacturing to custom panel specifications — organizations needing a different combination of specialty panels within a 19 panel card format can specify custom configurations through the OEM program
The 19 panel card — covering Gabapentin, Kratom, EtG, Fentanyl, and TCA alongside the complete 12 panel professional baseline and built-in ADLTX — represents the broadest available specialty-panel dip card profile from 12 Panel Now. For distributors building a complete specialty dip card portfolio for their client base, combining the 19 panel card (GABA, KRA, EtG, FEN, TCA, ADLTX) with the 18 panel card (KET, TRA, EtG, FEN, KRA, ADLTX) provides comprehensive coverage of all major specialty substance categories that standard screens miss. Minimum order quantities and setup timelines available on request.
For wholesale accounts, private label setup, and OEM specifications contact:
12 Panel Now — Wholesale and Private Label
801 N Congress Ave, Boynton Beach FL 33426
561-897-9238 | [email protected]
12panelnow.com/wholesale | 12panelnow.com/private-label
What 12 Panel Now Offers:
220,000 Sq. Ft. Mega
Warehouse
We operate one of the largest drug-testing fulfillment centers in the country, stocked and ready to ship every day.
Lowest Wholesale Pricing. Highest Commissions. Period.
We aggressively price our products so you win more deals, while paying industry-leading commissions to our partners.
Same-Day Blind Drop Shipping
We ship directly to your customers — no branding, no invoices, no paper trail back to us. You keep the relationship. We do the heavy lifting.
Private Label Available
Want your own brand on the box? We’ve got you covered.
Build equity while selling proven products.
Real-Time Partner Portal
Track every order, commission, and customer in one clean dashboard. No guessing. No spreadsheets. Total transparency.
Where 19 Panel Dip Cards Are Used
| Setting | Primary Applications | Why the 19 Panel Dip Card |
| MAT and Addiction Treatment Programs | Gabapentin misuse monitoring in opioid populations (the primary detection gap in most MAT settings), Kratom as opioid substitute detection, EtG alcohol abstinence monitoring per SAMHSA guidelines, FEN for fentanyl concurrent use, TCA for co-prescribed antidepressants, complete MAT compliance baseline (BUP/10ng, MTD, OPI/300, OXY/100) | GABA at 1000 ng/mL closes the single most documented detection gap in MAT populations — Gabapentin misuse that passes every standard screen. KRA at 500 ng/mL closes the Kratom gap. EtG covers weekly alcohol abstinence monitoring per SAMHSA MAT guidelines. TCA covers co-prescribed antidepressants documented in opioid treatment populations. FEN covers illicit supply contamination. All five specialty panels plus the complete MAT compliance baseline in one $1.05 card. |
| Correctional Facilities | Comprehensive institutional substance screening covering Gabapentin and Kratom — the two most documented legal-substance contraband that pass standard screens — alongside fentanyl supply detection, alcohol monitoring, TCA coverage, and ADLTX specimen validity for institutional integrity | Both Gabapentin and Kratom are legally obtainable and extensively documented as correctional facility contraband passing all standard screens. Fentanyl is confirmed in institutional drug supply in all 50 US states per CDC overdose data. ADLTX prevents specimen dilution evasion — critical in institutional collection environments. The 19 panel card closes all key institutional detection gaps simultaneously at $1.05 per collection event with built-in validity documentation. |
| Pain Management Clinics | Gabapentin co-prescription compliance monitoring (the most commonly co-prescribed adjunct in pain management), TCA co-prescription compliance for patients on complex pain regimens, FEN for fentanyl patch adherence or diversion screening, complete prescription opioid compliance suite (BUP/10ng, OXY/100ng, OPI/300ng, MTD) | Pain management patients are frequently co-prescribed both Gabapentin and tricyclic antidepressants alongside opioid analgesics. The 19 panel card verifies compliance with all co-prescribed medications simultaneously: GABA confirms Gabapentin adherence, TCA confirms tricyclic adherence, OXY/BUP/OPI/MTD confirms opioid adherence, FEN screens for illicit supplemental fentanyl use or patch diversion. ADLTX confirms specimen validity for clinical documentation. |
| Drug Courts and Probation | Court-ordered comprehensive substance monitoring covering legal-substance workarounds (Gabapentin, Kratom), TCA compliance where specified in supervision orders, EtG alcohol abstinence documentation, FEN for fentanyl supply exposure, ADLTX specimen validity evidence for legal proceedings | Per NADCP best practice standards, comprehensive monitoring including legal substance workarounds and emerging substances is recommended. Gabapentin and Kratom are the two most documented legal substance workarounds in court-supervised populations. ADLTX validity documentation is legally significant in proceedings. The 19 panel card covers the full court monitoring requirement profile in a single $1.05 card with built-in specimen integrity documentation. |
| Sober Living Programs | Weekly resident accountability with 80-hour EtG alcohol detection, Gabapentin monitoring for residents using it as a self-managed substance, Kratom monitoring for residents using it as a legal opioid alternative, fentanyl supply detection, full stimulant and opioid baseline | Sober living facilities conducting weekly collections need EtG at 300 ng/mL to cover most of the inter-test alcohol monitoring interval. Gabapentin and Kratom are the two most documented substances used by residents as legal alternatives to controlled substances that pass standard screens. The 19 panel card closes all three gaps simultaneously alongside FEN, TCA, and the complete professional baseline for $1.05 per collection event — the most cost-effective comprehensive specialty-panel accountability screen available in dip card format. |
19 Panel Drug Test Dip Card: Why Gabapentin and Kratom Are the Two Most Significant Detection Gaps in MAT Programs — and How This Card Closes Both
The 19 panel dip card from 12 Panel Now was designed around a specific clinical observation: two substances account for the majority of undetected substance use in opioid treatment populations, and neither appears on any standard drug test at any panel count. Those two substances are Gabapentin and Kratom.
Gabapentin (Neurontin) is prescribed for nerve pain and epilepsy but is widely used in opioid-adjacent populations because it potentiates opioid effects, reduces withdrawal discomfort, and produces its own sedative-euphoric effects at high doses. Per NIDA prescription drug misuse research, gabapentin misuse is significantly documented in opioid use disorder populations. Multiple US states have rescheduled gabapentin as a controlled substance at the state level due to documented misuse patterns. Despite this, every standard drug test at every panel count returns a negative Gabapentin result because no standard immunoassay panel includes a GAB antibody.
For MAT and addiction treatment programs, the 19 panel card closes the Gabapentin and Kratom gaps simultaneously at $1.05 per card in bulk — alongside EtG for alcohol monitoring, FEN for fentanyl concurrent use, TCA for co-prescribed antidepressants, and the complete MAT compliance baseline covering BUP/10ng, MTD, OPI/300ng, and OXY/100ng.
19 Panel Dip Card for Pain Management: Gabapentin and TCA Co-Prescription Compliance in One Card With the Full Opioid Baseline
Pain management clinics face a specific substance monitoring challenge not addressed by any standard multi-panel drug test: most patients are prescribed not just opioid analgesics but co-medications including Gabapentin (for neuropathic pain components), Tricyclic Antidepressants (for sleep and pain modulation), and sometimes Fentanyl transdermal patches. Verifying compliance with all three co-prescriptions simultaneously from a single urine collection event requires panels that standard 12 to 28 panel tests do not include.
The 19 panel dip card includes GABA at 1000 ng/mL (verifies Gabapentin prescription adherence), TCA at 1000 ng/mL (verifies tricyclic antidepressant adherence), and FEN at 20 ng/mL (screens for fentanyl patch adherence or diversion) alongside the complete prescription opioid compliance suite — BUP at 10 ng/mL, MTD at 300 ng/mL, OPI/MOR at 300 ng/mL, and OXY at 100 ng/mL. These six opioid and co-medication compliance panels run simultaneously in the same 5-minute dip event alongside AMP, BAR, BZO, COC, MDMA, MET, PCP, THC, and KRA, with ADLTX specimen validity built in.
For pain management programs currently running a standard 12 panel cup alongside separate Gabapentin strips and TCA strips for co-prescription monitoring, the 19 panel card consolidates the entire monitoring protocol into one $1.05 card per collection event. Contact 12 Panel Now at 561-897-9238 for bulk pricing and to discuss CLIA Waived configurations for clinical billing purposes.
What Does “Forensic Use Only” Mean for 19 Panel Dip Cards?
- How results are used: Forensic use only tests determine program compliance - whether someone violated probation conditions, sober living rules, or custody requirements. They do not diagnose substance use disorder or guide medical treatment. Many courts require laboratory confirmation (GC-MS or LC-MS/MS) before admitting screening results as evidence.
- What it means: The product has not undergone FDA 510(k) clearance - the premarket notification process for medical devices. The FDA exercises enforcement discretion over these products because forensic settings have evidentiary protections (rules of evidence, chain of custody, confirmation requirements) not present in clinical settings.
19 Panel Dip Card frequently asked questions
Yes. Many employers use 13 panel dip cards for random screening programs because they provide fast preliminary results and cover a broad range of commonly abused substances.
Certain prescription and over-the-counter medications may produce unexpected screening results. Any presumptive positive result should be confirmed through laboratory testing.
Yes. If additional substances need to be screened, multiple dip cards can be run using the same specimen, provided sufficient sample volume is available.
Answer: Many organizations use dip cards as an initial screening tool, sending only non-negative samples for confirmation, which may reduce overall testing expenses.
Yes. Because it requires minimal equipment, it is commonly used at construction sites, field operations, and other remote work locations.
Yes. Many workplaces use multi-panel drug tests after workplace incidents as part of their safety and compliance procedures.
Yes. Drug screening is often incorporated into broader workplace safety, compliance, and risk-management initiatives.
Yes. Testing providers often use multi-panel dip cards because they offer broad screening coverage while remaining cost-effective.
Expired tests should not be used. They should be discarded according to the manufacturer's instructions and replaced with in-date inventory.
Yes. Bulk packaging and rapid testing procedures make these dip cards suitable for organizations conducting large numbers of screenings.
Extreme temperatures can affect test performance. Always store and use the dip card according to the manufacturer's recommended temperature range.
Yes. Its compact design and rapid results make it a practical option for on-site and mobile drug testing programs.
An inadequate sample may prevent proper testing and result interpretation. A new specimen should be collected before testing.
Yes. Many professional testing programs maintain chain-of-custody records to document specimen handling and result integrity.
Organizations should periodically evaluate their testing needs to ensure their chosen panel matches current substance abuse trends and program requirements.
Basic instruction on specimen collection, timing, and result interpretation is recommended to ensure consistent and accurate testing procedures.
The best configuration depends on the substances most relevant to the organization's monitoring goals, compliance requirements, and testing policies.
Yes. Many employers and treatment programs include drug testing as part of return-to-duty or ongoing compliance monitoring procedures.
Organizations typically maintain documentation related to specimen collection, test results, testing dates, and any required confirmation testing.
What Are 19 Panel Drug Tests?
A 19 panel drug test is a powerful diagnostic tool that can detect the presence of multiple substances in a single urine specimen. It screens for 19 commonly abused drugs. Additionally, this test includes adulteration checks to identify tampered samples, ensuring accurate results.
Who Uses 19 Panel Drug Tests?
This test is highly valued across various industries, including:
- Workplaces: Employers use it to maintain drug-free environments and ensure employee safety. Especially in industries like transportation, healthcare, and manufacturing, where impairment can pose severe risks.
- Rehabilitation Centers: Clinics benefit from its ability to test for both traditional and synthetic drugs in patients under treatment for substance misuse.
- Schools and Sports Organizations: Educational institutions and athletic bodies use these tests to deter drug use and enforce zero-tolerance policies.
- Law Enforcement and Legal Settings: Parole offices and legal entities rely on 19 panel testing for probation screenings and court cases.
Whether you're a small business or part of a large organization, the 19 panel drug test ensures comprehensive drug detection in a single, straightforward process.
Why Choose 12 Panel Now for Your Drug Testing Needs?
When it comes to bulk ordering drug tests, 12 Panel Now is a trusted supplier for workplaces, healthcare centers, and other professional environments. With millions of tests in stock and a reliable, customer-focused approach, here's why 12 Panel Now stands out.
Comprehensive Product Range
12 Panel Now offers a wide variety of tests, including the 19 panel drug test, which is ideal for organizations needing to screen for a broad range of substances. Other panel options are available too, ranging from 5 to 28 panels, to suit specific testing needs.
Tailored Bulk Options
Whether you need a few dozen tests or thousands, 12PanelNow provides customized bulk solutions with significant cost savings. From dip cards to drug test cups with temperature strips, you can select the format that works best for your workplace or program. To inquire about bulk discounts, simply contact their team.
Key Features of 19 Panel Drug Tests from 12PanelNow
- Accuracy: Tests are 99% accurate, ensuring reliability.
- Ease of Use: The urine-based tests feature quick and straightforward procedures, showing results within minutes.
- Adulteration Detection: Built-in checks detect tampering, providing an added layer of assurance.
- Fast Shipping: Same-day shipping is available, with free shipping on larger bulk purchases.
Dedicated Customer Support
12 Panel Now takes pride in exceptional customer service. From helping clients choose the right products to offering insights into drug test results, their knowledgeable team is always ready to assist.
Additional Benefits for Subscribers
By subscribing to 12 Panel Now's products, customers can save 5% on recurring orders, making it even more convenient and affordable to maintain a regular stock of drug tests.
Order from 12 Panel Now Today!
The 19 panel drug test is the ideal solution for comprehensive drug screening. Covering both traditional substances and synthetic drugs, it offers peace of mind to employers, healthcare professionals, and organizations aiming to maintain safe, compliant environments.
By choosing 12 Panel Now as your supplier, you're investing in reliability, efficiency, and cost savings. Their vast product range, tailored bulk options, and unbeatable customer service make them the go-to choice for businesses big and small. And with same-day shipping and significant bulk discounts, staying prepared has never been easier.
